Onconova Therapeutics (NASDAQ:ONTX – Get Free Report) and ProMIS Neurosciences (NASDAQ:PMN – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, dividends and valuation. Profitability This table compares Onconova Therapeutics and […]
StockNews.com started coverage on shares of Onconova Therapeutics (NASDAQ:ONTX – Free Report) in a research note published on Saturday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Separately, HC Wainwright raised Onconova Therapeutics from a neutral rating to a buy rating and set a $11.00 price objective on the stock in a […]
StockNews.com began coverage on shares of Onconova Therapeutics (NASDAQ:ONTX – Free Report) in a research report released on Friday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Separately, HC Wainwright raised Onconova Therapeutics from a neutral rating to a buy rating and set a $11.00 price target for the company in […]
Analysts at StockNews.com started coverage on shares of Onconova Therapeutics (NASDAQ:ONTX – Free Report) in a research note issued to investors on Friday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock. Separately, HC Wainwright raised shares of Onconova Therapeutics from a “neutral” rating to a “buy” rating and set a $11.00 price […]
StockNews.com started coverage on shares of Onconova Therapeutics (NASDAQ:ONTX – Get Rating) in a research report sent to investors on Thursday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Separately, HC Wainwright upgraded shares of Onconova Therapeutics from a neutral rating to a buy rating and set a $11.00 target price […]